Relay Therapeutics Inc. is a clinical-stage precision medicine company that focuses on leveraging insights from protein motion to design breakthrough drugs. The company’s platform combines computational simulations, biophysical techniques, and machine learning to discover and develop novel therapies for cancer and other diseases. With a strong emphasis on innovation and scientific excellence, Relay Therapeutics is poised to make a significant impact in the field of drug discovery.
